[EN] SPIROINDOLINONES AS DDR1 INHIBITORS<br/>[FR] SPIROINDOLINONES UTILISÉS EN TANT QU'INHIBITEURS DE DDR1
申请人:HOFFMANN LA ROCHE
公开号:WO2017137334A1
公开(公告)日:2017-08-17
The present invention relates to compounds of formula (I): or pharmaceutically acceptable salts thereof, as well as processes for their manufacture, pharmaceutical compositions comprising them, and their use as medicaments.
本发明涉及式(I)的化合物或其药用盐,以及其制备方法、包含它们的药物组合物,以及它们作为药物的用途。